Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa
- Conditions
- HIV Prevention
- Registration Number
- NCT01554423
- Lead Sponsor
- The City College of New York
- Brief Summary
This study is a Randomized Controlled Trial (RCT) of Integrated and Cognitive Behavioral Therapy for HIV Prevention in Pretoria, South Africa. The RCT will evaluate the efficacy of a brief motivational interview (BMI) and a cognitive-behavioral couples' (IFCBT) intervention alone and in combination against a comparison condition to reduce new cases of HIV and sexually transmitted infections and increase condom use and decrease sexual risk behavior, drug use, and intimate partner violence among young female drug users in Pretoria, South Africa and their primary intimate partners. In the RCT, 384 couples comprised of young female drug users who do (N = 192) and do not (N = 192) trade sex and their primary intimate heterosexual partners will be randomly assigned to one-of-four conditions: (1) testing and counseling; (2) brief motivational interview (BMI); (3) cognitive-behavioral couples' intervention (IFCBT); or (4) BMI and IFCBT combined. Eligibility criteria for couples include an HIV-negative drug using female aged 18 to 40 and their primary intimate partner or spouse who is also HIV negative. Each partner of each couple will be administered assessments with a rapid test for HIV and urine tests for Chlamydia, gonorrhea, trichomoniasis, and drug use at baseline and 3-month, 6-month, and 12-month follow-up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 464
- Live in the Pretoria, South Africa region
- 18-40 Years of Age
- In a steady, intimate relationship for 6 months or longer
- Used illicit drugs in the past 6 months
- Acute suicidality/homicidality
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Drug taking risk behavior Outcome measure will be assessed up to 18 months after enrollment. Hazardous alcohol use, and positive urinalysis for marijuana, cocaine, heroin.
Biologically confirmed infectious disease status Outcome measure will be assessed up to 18 months after enrollment. Biologically confirmed infectious disease (HIV, Chlamydia, gonorrhea, and trichomoniasis)
Intimate partner violence Outcome measure will be assessed up to 18 months after enrollment. Psychological, physical, and sexual violence.
Condom use and sexual risk behavior Outcome measure will be assessed up to 18 months after enrollment. Condom use during last sexual intercourse, proportion of unprotected sex episodes; number of partners.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Louis Pasteur Medical Centre
🇿🇦Pretoria, Gauteng, South Africa
Louis Pasteur Medical Centre🇿🇦Pretoria, Gauteng, South Africa